专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明授权

US08126958B2 System and method for billing system interface failover resolution 有权
标题翻译：计费系统接口故障切换解决方案的系统和方法
公开(公告)号：US08126958B2
公开(公告)日：2012-02-28
申请号：US13189524
申请日：2011-07-24
申请人： Naresh Kumar , Robert Perry
发明人： Naresh Kumar , Robert Perry
IPC分类号： G06F15/16 , G06F15/173 , H04N7/16 , H04N7/173
CPC分类号： H04L12/14 , G06F11/2033 , G06F11/2038 , G06F11/2041 , H04L12/1403 , H04L69/40 , H04M15/70 , H04M15/74 , H04M2215/70 , H04M2215/709
摘要： A determination is made whether a first application server of a group of N application servers, N being at least two, is a coordinator of the group. Responsive to determining that the first application server is the coordinator of the group, a connection to a billing system is established, via a terminal server, by the first application server. A determination is made whether a second application server of the group of N application servers is the coordinator of the group. Responsive to determining that the second application server is not the coordinator of the group, a periodic check is made whether the second application server of the group of N application servers is the coordinator of the group. The second application server may later be determined to be the coordinator of the group, when the first server experiences difficulty. Once it is determined that the second application server now is the coordinator of the group, a connection is established to the billing system, via the terminal server, by the second application server.
摘要翻译：确定一组N个应用服务器的第一应用服务器是否为该组的协调器，N至少为两个。响应于确定第一应用服务器是该组的协调器，通过终端服务器由第一应用服务器建立与计费系统的连接。确定N个应用服务器组的第二应用服务器是否是该组的协调器。响应于确定第二应用服务器不是组的协调器，定期检查N个应用服务器组中的第二应用服务器是否是该组的协调器。当第一服务器遇到困难时，可以将第二应用服务器确定为该组的协调器。一旦确定第二应用服务器现在是组的协调器，则通过第二应用服务器经由终端服务器向计费系统建立连接。

52. 发明申请

US20110046722A1 OXAZINYL ISOFLAVONOID COMPOUNDS, MEDICAMENTS AND USE 失效
标题翻译： OXAZINYL ISOFLAVONOID化合物，药物和用途
公开(公告)号：US20110046722A1
公开(公告)日：2011-02-24
申请号：US12528208
申请日：2008-02-29
申请人： Andrew Heaton , Naresh Kumar , Catherine Walker
发明人： Andrew Heaton , Naresh Kumar , Catherine Walker
IPC分类号： A61F2/82 , C07D498/04 , A61K31/5365 , A61P9/00 , A61P29/00 , A61P39/06
CPC分类号： C07D498/04
摘要： The invention provides oxazinyl isoflavonoid compounds and compositions containing same, methods for their preparation and their use as therapeutic agents particularly as cardioprotective, anti-inflammatory, anti-oxidant and chemotherapeutic agents.
摘要翻译：本发明提供了恶嗪基异黄酮化合物和含有其的组合物，其制备方法及其作为治疗剂的用途，特别是作为心脏保护剂，抗炎剂，抗氧化剂和化学治疗剂。

53. 发明申请

US20100035948A1 Furanone compounds and lactam analogues thereof 有权
标题翻译：呋喃酮化合物及其内酰胺类似物
公开(公告)号：US20100035948A1
公开(公告)日：2010-02-11
申请号：US12311473
申请日：2007-10-08
申请人： Naresh Kumar , George Iskander
发明人： Naresh Kumar , George Iskander
IPC分类号： A61K31/42 , C07D307/02 , A61K31/341 , C07D409/02 , A61K31/381 , C07D261/00 , C07D231/10 , A61K31/415 , C07D207/18 , A61K31/40 , A61P31/04 , A61P31/10 , A61P33/02 , A01N43/08 , A01N43/10 , A01N43/80 , A01N43/56 , A01N43/36
CPC分类号： C07D307/58 , C07D207/38 , C07D405/04 , C07D409/04 , C07D409/06
摘要： The present invention provides a compound of formula I and a compound of formula II, methods of use and formulations thereof.
摘要翻译：本发明提供式I化合物和式II化合物，其用途及其制剂。

54. 发明授权

US07378535B2 Production of furanones 失效
标题翻译：生产呋喃酮
公开(公告)号：US07378535B2
公开(公告)日：2008-05-27
申请号：US11414552
申请日：2006-05-01
申请人： Roger Read , Naresh Kumar
发明人： Roger Read , Naresh Kumar
IPC分类号： C07D307/58
CPC分类号： C08F20/00 , A01N43/08 , C07D307/58 , C08F24/00
摘要： The present invention relates to the side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones) and their synthetic analogues, that yields fimbrolides substituted with a halogen, an oxygen or a nitrogen functionality in the alkyl chain, especially fimbrolide alcohols, carboxylate and sulfinate and sulfonate esters, ethers, aldehydes, ketones, acids, amides, nitro derivatives, hydrophobic, hydrophilic and fluorophilic alkyl derivatives and polymers.
摘要翻译：本发明涉及福滨洛尔（卤代3-烷基-5-亚甲基-2（5H） - 呋喃酮）及其合成类似物的侧链官能化，其产生在烷基中被卤素，氧或氮官能团取代的菲莫拉林链，特别是福美罗瑞醇，羧酸盐和亚磺酸盐和磺酸酯，醚，醛，酮，酸，酰胺，硝基衍生物，疏水性，亲水和氟化烷基衍生物和聚合物。

55. 发明申请

US20080014249A1 Compositions and therapeutic methods involving isoflavones and analogues thereof 审中-公开
标题翻译：涉及异黄酮及其类似物的组合物和治疗方法
公开(公告)号：US20080014249A1
公开(公告)日：2008-01-17
申请号：US11901724
申请日：2007-09-17
申请人： Andrew Heaton , Naresh Kumar , Graham Kelly , Alan Husband
发明人： Andrew Heaton , Naresh Kumar , Graham Kelly , Alan Husband
IPC分类号： A61K47/00 , A61K31/35 , A61P29/00 , A61K31/355
CPC分类号： C07D311/26 , A23L33/10 , A23L33/11 , A23V2002/00 , C07D311/36 , C07D311/38 , C07D311/58 , C07D471/06 , A23V2250/2116 , A23V2200/30
摘要： Isoflavone compounds are described and recommended as therapeutic agents. Exemplified and preferred compounds are (a). Indications show compounds have good competitive binding to estrogen receptors. This is exemplified.
摘要翻译：描述和推荐异黄酮化合物作为治疗剂。示例性和优选的化合物是（a）。适应症显示化合物与雌激素受体具有良好的竞争性结合。这是例证。

56. 发明申请

US20070261107A1 Method and apparatus for managing bootstrap credentials for credentials-storage systems 有权
标题翻译：用于管理凭据存储系统的引导凭据的方法和装置
公开(公告)号：US20070261107A1
公开(公告)日：2007-11-08
申请号：US11418051
申请日：2006-05-03
申请人： Raymond Ng , Ganesh Kirti , Thomas Keefe , Naresh Kumar
发明人： Raymond Ng , Ganesh Kirti , Thomas Keefe , Naresh Kumar
IPC分类号： H04L9/32
CPC分类号： H04L63/062
摘要： One embodiment of the present invention provides a system that facilitates accessing a credential. During operation, the system receives a request at a credentials-storage framework (CSF) to retrieve the credential. If a target credential store containing the credential is not already connected to the CSF, the system looks up a bootstrap credential for the target credential store in a bootstrap credential store, which contains bootstrap credentials for other credential stores. Next, the system uses this bootstrap credential to connect the CSF to the target credential store. Finally, the system retrieves the credential from the target credential store, and returns the credential to the requestor.
摘要翻译：本发明的一个实施例提供一种便于访问证书的系统。在操作期间，系统在凭证存储框架（CSF）处接收请求以检索凭证。如果包含凭据的目标凭据存储库尚未连接到CSF，则系统将在引导凭证存储中查找目标凭据存储的引导凭据，其中包含其他凭据存储的引导凭据。接下来，系统使用此引导凭据将CSF连接到目标凭据存储。最后，系统从目标凭证存储中检索凭证，并将凭证返回给请求者。

57. 发明申请

US20070136819A1 Dynamic conditional security policy extensions 有权
标题翻译：动态条件安全策略扩展
公开(公告)号：US20070136819A1
公开(公告)日：2007-06-14
申请号：US11296086
申请日：2005-12-06
申请人： Raymond Ng , Ganesh Kirti , Thomas Keefe , Naresh Kumar
发明人： Raymond Ng , Ganesh Kirti , Thomas Keefe , Naresh Kumar
IPC分类号： H04L9/32
CPC分类号： H04L63/08
摘要： Systems, methods, and machine-readable media are disclosed for providing conditional grants of permission in an externally configured security policy. In one embodiment, a method is provided which comprises reading a condition clause from a grant statement defined in the security policy. The grant statement can cause the granting of permission for a user to access a requested resource. One or more constraints on the grant statement can be determined based on the condition clause. Permission can be granted to access the requested resource based on the one or more constraints.
摘要翻译：公开了用于在外部配置的安全策略中提供有限许可的系统，方法和机器可读介质。在一个实施例中，提供了一种方法，其包括从安全策略中定义的授权语句读取条件子句。授权语句可能导致授予用户访问所请求资源的权限。授权语句的一个或多个约束可以基于条件子句来确定。可以授予权限以基于一个或多个约束来访问所请求的资源。

58. 发明授权

US07064220B1 Production of furanones 失效
标题翻译：生产呋喃酮
公开(公告)号：US07064220B1
公开(公告)日：2006-06-20
申请号：US09673305
申请日：1999-04-16
申请人： Roger Read , Naresh Kumar
发明人： Roger Read , Naresh Kumar
IPC分类号： C07D307/58 , A01N43/08
CPC分类号： C08F20/00 , A01N43/08 , C07D307/58 , C08F24/00
摘要： The present invention relates to the side chain functionalization of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones) and their synthetic analogues, that yields fimbrolides substituted with a halogen, an oxygen or a nitrogen functionality in the alkyl chain, especially fimbrolide alcohols, carboxylate and sulfinate and sulfonate esters, ethers, aldehydes, ketones, acids, amides, nitro derivatives, hydrophobic, hydrophilic and fluorophilic alkyl derivatives and a polymers.
摘要翻译：本发明涉及福滨洛尔（卤代3-烷基-5-亚甲基-2（5H） - 呋喃酮）及其合成类似物的侧链官能化，其产生在烷基中被卤素，氧或氮官能团取代的菲莫拉林链，特别是福美罗瑞醇，羧酸酯和亚磺酸盐和磺酸酯，醚，醛，酮，酸，酰胺，硝基衍生物，疏水性，亲水和氟化烷基衍生物和聚合物。

59. 发明授权

US07052910B2 Skeletal cell model to screen anti-diabetic compounds 有权
公开(公告)号：US07052910B2
公开(公告)日：2006-05-30
申请号：US09984018
申请日：2001-10-26
申请人： Naresh Kumar , Chinmoy Sankar Dey
发明人： Naresh Kumar , Chinmoy Sankar Dey
IPC分类号： C12N5/06 , C12N5/00 , C12N5/02
CPC分类号： C07K16/18 , C07K16/26 , C07K16/2869 , G01N33/5061 , G01N2800/042
摘要： The present invention relates to the development of insulin resistant skeletal muscle cell culture model useful for the screening of compounds that enhance insulin receptor (IR) and insulin receptor substrate-1 (IRS-1) tyrosine phosphorylation required against type II diabetes.

60. 发明授权

US06677485B2 Process for the preparation of fluoxetine hydrochloride 失效
标题翻译：盐酸氟西汀的制备方法
公开(公告)号：US06677485B2
公开(公告)日：2004-01-13
申请号：US10149624
申请日：2002-08-09
申请人： Naresh Kumar , Bakthavathsalan Vijayaraghavan , Kinali Venkata Ramana , Swargam Sathyanarayana
发明人： Naresh Kumar , Bakthavathsalan Vijayaraghavan , Kinali Venkata Ramana , Swargam Sathyanarayana
IPC分类号： C07C21702
CPC分类号： C07C213/06 , C07C217/48
摘要： An improved and industrially advantageous process for the preparation of the antidepressant fluoxetine and its pharmaceutically acceptable salts, preferably hydrochloride.
摘要翻译：一种用于制备抗抑郁药氟西汀及其药学上可接受的盐，优选盐酸盐的改进和工业上有利的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式